Navigation Links
National Award Recognizes Delmarva Foundation and CareFirst BlueCross BlueShield Quality Improvement Efforts
Date:10/11/2007

Program Receives 2007 Distinctively Blue Award for Hospital Quality Improvement

BALTIMORE, Oct. 11 /PRNewswire-USNewswire/ -- Successful efforts to reduce hospital-acquired infections in the mid-Atlantic region were recently honored with a national award from the BlueCross BlueShield Association of America. CareFirst BlueCross BlueShield (CareFirst) received the 2007 Distinctively Blue Award for Innovations for the 100,000 Lives and Beyond Collaborative. CareFirst and the Delmarva Foundation for Medical Care, a healthcare quality improvement organization, work jointly on this ongoing program to improve the quality of care in local hospitals.

CareFirst and Delmarva Foundation are working together to build on national patient safety focus areas, including the Institute for Healthcare Improvement (IHI) 100,000 Lives and 5 Million Lives campaigns.

"Delmarva Foundation is an outstanding partner with us on a number of fronts," said Dr. Jon Shematek, CareFirst Senior Vice President and Chief Medical Officer. "We are making measurable strides in improving health care quality and this award confirms the progress we are seeing."

The 100,000 Lives and Beyond Collaborative, a program offered by Delmarva Foundation with financial support from CareFirst, ran from January 2006 to January 2007. Delmarva worked with 28 hospitals from Maryland, the District of Columbia, and northern Virginia to implement evidence-based strategies to improve the process of care and clinical outcomes in the intensive care unit (ICU) and operating room (OR). The 100,000 Lives and Beyond Collaborative aligned national and regional regulatory and accreditation patient safety goals and priorities with clinically relevant outcomes and local priorities.

Highlighted results from the 100,000 Lives and Beyond Collaborative include:

-- 53% of reporting ICU teams improved compliance with key processes that

can reduce ventilator-associated pneumonia cases; 67% of teams reduced

rates of these infections to zero.

-- 80% of OR teams improved the timing of antibiotics before surgery,

which can reduce rates of surgical infections. In addition, 80% of

teams reported no surgical infections at the end of the

collaborative.

We are so proud of the accomplishments of the hospitals involved in the 100,000 Lives and Beyond Collaborative," commented Dr. Margaret Toth, Delmarva's Chief Quality Officer. "Delmarva and CareFirst are natural partners that continue to be innovative leaders with work on healthcare-associated infections. We look forward to continuing our efforts to improve the quality of healthcare in these important settings."

The Distinctively Blue Award program recognizes quality programs deployed by BlueCross BlueShield-affiliated plans. Of 61 submissions, 6 awards and 2 honorable mentions were given at the BlueCross BlueShield Distinctively Blue Conference.

For more information regarding Delmarva Foundation and quality improvement collaboratives, contact: Bonnie Noble at nobleb@dfmc.org

Delmarva Foundation is a national, not-for-profit organization dedicated to improving healthcare quality in over 30 states. Since 1973, Delmarva has assisted in enhancing care in hospitals, nursing homes, home health agencies, medical practices and health plans. Delmarva conducts work ranging from quality improvement, quality assurance, utilization review to external quality review. The company's corporate headquarters are located in Easton, Maryland with other offices in Baltimore, Maryland; Washington, DC; and Tampa and Tallahassee, Florida. For more information, please visit Delmarva Foundation on the web at http://www.delmarvafoundation.org.


'/>"/>
SOURCE Delmarva Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. International community warns India on HIV situation
2. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
3. National Lung Study in the process
4. Indian Nationals with Foreign Medical Degrees can now practice in India
5. Key step forward on International Health Rules
6. ICMR along with other International Research organisation with drug development for Neglected Diseases
7. International Osteoporosis Research Centre To Be Started In India.
8. Hepatitis B Vaccine To Be Included In National Immunization Programme
9. Indian hospitals require International Accreditation
10. International Conference On Malaria - Laveran To Genomics
11. UK Govt Says On Course For National Chlamydia Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 2016 , ... "I had a terrible time trying to get my grandson ... if the nebulizer had a more child-friendly design, then children would be more likely ... patent-pending NEBY to avoid the need to deliver medication via a nebulizer mask. The ...
(Date:12/8/2016)... ... 2016 , ... The West Virginia Medical Institute (WVMI) announced ... name change aligns the entire company with its existing Quality Insights branded projects ... are very proud of the achievements associated with the West Virginia Medical Institute ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying ... opened registration today for its 33rd Annual Issues & Research Conference, March ... The theme of the conference is “Persistent Challenges and New Opportunities: Using Research ...
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc , a New ... Conventional Data Capture Methods for Input to Electronic Health Records: A Comparative Usability ... the comparative usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s ...
(Date:12/8/2016)... Virginia (PRWEB) , ... December 08, 2016 , ... ... services company offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care ... operations and general counsel and Eric Hoessel to vice president of sales. ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016   Hudes Laser ... December featuring the multi-wavelength Astanza Trinity laser and ... specializes in laser tattoo removal, IPL hair removal, ... ultrasound therapy. Hudes Laser Aesthetica is setting high ... and promises to deliver effective, long-lasting ...
(Date:12/9/2016)... 2016 Mitsubishi Tanabe Pharma Corporation (Head Office: ... CEO: Dr. Masayuki Mitsuka ) has presented data ... edaravone intravenously in 10-14 day cycles for 48 weeks ... ALS Functional Rating Scale-Revised (ALSFRS-R). The data were presented ... in Dublin, Ireland . ...
(Date:12/9/2016)... , Dec. 9, 2016  Axovant Sciences ... clinical-stage biopharmaceutical company focused on the treatment of ... data from a Phase 2b trial evaluating treatment ... donepezil, compared with donepezil plus placebo in people ... the addition of intepirdine to treatment was associated ...
Breaking Medicine Technology: